Credit Suisse First Boston

Europe, Zurich, Switzerland, Zurich

Description

Credit Suisse First Boston was the investment banking division of Credit Suisse Group.

Investor Profile

Credit Suisse First Boston has backed more than 47 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 11% of its total and boasts 22 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series Unknown, Series C, Series B rounds (top funding stages).
Majority of deals are located in United States, United Kingdom, Bermuda.
Strong thematic focus on Internet, Information Technology, Health Care.

Stage Focus

Series Unknown (32%)
Series C (26%)
Series B (15%)
Private Equity (9%)
Series E (6%)
Series D (6%)
Debt Financing (2%)
Post Ipo Equity (2%)
Series F (2%)

Country Focus

United States (91%)
United Kingdom (4%)
Bermuda (2%)
Canada (2%)

Industry Focus

Internet
Information Technology
Health Care
Software
Biotechnology
Enterprise Software
Manufacturing
Service Industry
Telecommunications
E-commerce

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Credit Suisse First Boston frequently co-invest with?

Abingworth

Europe, England, United Kingdom, London

Co-Investments: 4

Chase Capital Partners

North America, New York, United States, New York

Co-Investments: 4

Morgan Stanley Dean Witter

North America, New York, United States, New York

Co-Investments: 4

New Enterprise Associates

North America, California, United States, Menlo Park

Co-Investments: 6

Focus Ventures

North America, California, United States, Palo Alto

Co-Investments: 4

Brinson Partners

North America, Illinois, United States, Chicago

Co-Investments: 3

Access Technology Partners

North America, Connecticut, United States, Shelton

Co-Investments: 4

Sands Brothers Asset Management

North America, New York, United States, New York

Co-Investments: 3

Wheatley Partners

North America, New York, United States, Great Neck

Co-Investments: 6

Merrill Lynch

North America, New York, United States, New York

Co-Investments: 4

Which angels does Credit Suisse First Boston often collaborate with?

William Hambrecht

North America, California, United States, San Francisco

Shared Deals: 1

Ted Waitt

North America, California, United States, La Jolla

Shared Deals: 1

Stratton Sclavos

North America, California, United States, Los Angeles

Shared Deals: 1

Marc Benioff

North America, California, United States, San Francisco

Shared Deals: 1

Naren Gupta

North America, California, United States, Menlo Park

Shared Deals: 1

Allen Miner

Asia, Tokyo, Japan, Tokyo

Shared Deals: 1

Halsey Minor

North America, California, United States, Los Angeles

Shared Deals: 1

What are some of recent deals done by Credit Suisse First Boston?

PTC Therapeutics

South Plainfield, New Jersey, United States

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.

BiotechnologyHealth CareTherapeutics

Series FFeb 5, 2007

Amount Raised: $10,000,000

CELLFOR

Vancouver, British Columbia, Canada

CellFor is a forest biotechnology company producing somatic embryos of loblolly pine seedlings.

BiotechnologyGeneticsGreenTechManufacturing

Series UnknownOct 22, 2006

Amount Raised: $5,608,750

Sunesis Pharmaceuticals

South San Francisco, California, United States

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

BiotechnologyHealth CareOncologyPharmaceutical

Series CSep 16, 2004

Amount Raised: $14,000,000

PTC Therapeutics

South Plainfield, New Jersey, United States

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.

BiotechnologyHealth CareTherapeutics

Series EJun 23, 2004

Amount Raised: $15,000,000

Upstream Technologies

Boston, Massachusetts, United States

Upstream Technologies is a leading technology provider for the Separate Accounts Industry.

FinTechInformation ServicesInformation TechnologySoftwareTechnical Support

Series UnknownJun 23, 2004

PTC Therapeutics

South Plainfield, New Jersey, United States

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.

BiotechnologyHealth CareTherapeutics

Series EJan 7, 2004

Amount Raised: $35,000,000

Sunesis Pharmaceuticals

South San Francisco, California, United States

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

BiotechnologyHealth CareOncologyPharmaceutical

Series CDec 20, 2002

Amount Raised: $6,000,000

Aspen Insurance Holdings Limited

Hamilton, Hamilton, Bermuda

Aspen is a global insurance and reinsurance company.

ConsultingFinanceFinancial ServicesInsuranceRisk ManagementTransportation

Private EquityJun 1, 2002

Amount Raised: $654,335,557

Oblix

Cupertino, California, United States

Oblix develops identity-based security and provides web access management solutions for e-commerce networks.

E-CommerceEnterprise SoftwareIdentity ManagementInformation TechnologyInternetSecurityShopping

Series UnknownJan 2, 2002

Amount Raised: $40,000,000

Sabeus Photonics

Calabasas, California, United States

Sabeus Photonics optical devices and expand manufacturing facilities. Sabeus supplies optical communications components.

ManufacturingOptical CommunicationTelecommunications

Series CDec 11, 2001

Amount Raised: $16,000,000

Credit Suisse First Boston

Description

Investor Profile

Investment Focus Highlights

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Credit Suisse First Boston frequently co-invest with?

Which angels does Credit Suisse First Boston often collaborate with?

What are some of recent deals done by Credit Suisse First Boston?

Ready to Raise Capital?

Pages

Free tools